Business Description
Healthlead PCL
ISIN : THA598010009
Description
Healthlead PCL is a holding company. Along with its subsidiaries, it operates a pharmacy business under iCare, Pharmax, vitaminclub, and Super Drug brands, distributing medicines, medical supplies, cosmeceuticals, dietary supplements, medical devices, and other healthcare products. Additionally, it is involved in co-inventing and co-developing healthcare products in collaboration with external research teams and contract manufacturers, producing and distributing its own branded products. Geographically, the group operates only in Thailand.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.66 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.34 | |||||
Debt-to-EBITDA | 1.54 | |||||
Interest Coverage | 6.39 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.72 | |||||
Beneish M-Score | -2.76 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 14.1 | |||||
3-Year EBITDA Growth Rate | 4.1 | |||||
3-Year EPS without NRI Growth Rate | -12.3 | |||||
3-Year FCF Growth Rate | 118.7 | |||||
3-Year Book Growth Rate | 1.1 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 81.59 | |||||
9-Day RSI | 68.92 | |||||
14-Day RSI | 59.59 | |||||
3-1 Month Momentum % | -14.06 | |||||
6-1 Month Momentum % | -22.54 | |||||
12-1 Month Momentum % | -22.54 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.03 | |||||
Quick Ratio | 1.85 | |||||
Cash Ratio | 1.71 | |||||
Days Inventory | 69.67 | |||||
Days Sales Outstanding | 0.9 | |||||
Days Payable | 39.56 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 3.79 | |||||
Dividend Payout Ratio | 0.78 | |||||
3-Year Dividend Growth Rate | 2 | |||||
Forward Dividend Yield % | 3.79 | |||||
5-Year Yield-on-Cost % | 3.79 | |||||
3-Year Average Share Buyback Ratio | 0.2 | |||||
Shareholder Yield % | 9.18 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 24.48 | |||||
Operating Margin % | 4.87 | |||||
Net Margin % | 3.38 | |||||
EBITDA Margin % | 9.28 | |||||
FCF Margin % | 6.77 | |||||
OCF Margin % | 8.08 | |||||
ROE % | 7.77 | |||||
ROA % | 4.97 | |||||
ROIC % | 11.04 | |||||
3-Year ROIIC % | -11.95 | |||||
ROC (Joel Greenblatt) % | 16.9 | |||||
ROCE % | 8.88 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 20.71 | |||||
Forward PE Ratio | 14.15 | |||||
PE Ratio without NRI | 20.64 | |||||
Price-to-Owner-Earnings | 10.39 | |||||
PEG Ratio | 1.79 | |||||
PS Ratio | 0.69 | |||||
PB Ratio | 1.57 | |||||
Price-to-Tangible-Book | 1.61 | |||||
Price-to-Free-Cash-Flow | 10.21 | |||||
Price-to-Operating-Cash-Flow | 8.55 | |||||
EV-to-EBIT | 11.2 | |||||
EV-to-EBITDA | 6.07 | |||||
EV-to-Revenue | 0.56 | |||||
EV-to-FCF | 8.32 | |||||
Price-to-GF-Value | 0.53 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.3 | |||||
Price-to-Graham-Number | 1.22 | |||||
| Price-to-Net-Current-Asset-Value | 4.46 | |||||
Earnings Yield (Greenblatt) % | 8.93 | |||||
FCF Yield % | 10.31 | |||||
Forward Rate of Return (Yacktman) % | 19.44 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Healthlead PCL Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ฿) | 2,244.185 | ||
| EPS (TTM) (฿) | 0.28 | ||
| Beta | 0.4556 | ||
| 3-Year Sharpe Ratio | -1.04 | ||
| 3-Year Sortino Ratio | -1.19 | ||
| Volatility % | 17.36 | ||
| 14-Day RSI | 59.59 | ||
| 14-Day ATR (฿) | 0.118801 | ||
| 20-Day SMA (฿) | 5.65 | ||
| 12-1 Month Momentum % | -22.54 | ||
| 52-Week Range (฿) | 5.4 - 8.45 | ||
| Shares Outstanding (Mil) | 253.99 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Healthlead PCL Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Healthlead PCL Stock Events
| Event | Date | Price (฿) | ||
|---|---|---|---|---|
| THB 0.220000 Cash Dividend | 2026-03-11 | 6.90 (+0.00%) | ||
| THB 0.170000 Cash Dividend | 2025-03-14 | 7.25 (+1.40%) |
Show
Entries
Healthlead PCL Frequently Asked Questions
What is Healthlead PCL(BKK:HL)'s stock price today?
The current price of BKK:HL is ฿5.80. The 52 week high of BKK:HL is ฿8.45 and 52 week low is ฿5.40.
When is next earnings date of Healthlead PCL(BKK:HL)?
The next earnings date of Healthlead PCL(BKK:HL) is .
Does Healthlead PCL(BKK:HL) pay dividends? If so, how much?
The Dividend Yield %  of Healthlead PCL(BKK:HL) is 3.79% (As of Today), Highest Dividend Payout Ratio of Healthlead PCL(BKK:HL) was 0.78. The lowest was 0.37. And the median was 0.57. The  Forward Dividend Yield % of Healthlead PCL(BKK:HL) is 3.79%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Healthlead PCL
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers